DUBLIN--(BUSINESS WIRE)--The "Biosimilars: Global Markets" report has been added to ResearchAndMarkets.com's offering.
Biosimilars are replicas of the innovator biopharmaceuticals. They offer the advantage of being less expensive as compared to their expensive counterparts. The structural and manufacturing complexities associated with their development have led to extensive approval guidelines and regulations by the federal agencies. This report examines the biosimilar drugs in detail and provides an updated overview including its applications in various arenas of disease sectors. The importance of analytical technologies in the biosimilar manufacturing led the researchers to focus specifically on the current and emerging trends in biosimilar manufacturing and analytical testing.
The researchers analyze each market and its application, new products and advancements, market projections and market shares.
Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the biosimilar drugs industry. The company profiles highlight the bosimilar pipelines of relevant companies.
The publisher analyzes the current market situation by critically discussing the strengths, weaknesses, threats, and opportunities for the global biosimilars market. The market projections and market shares are examined for each region and type. The latest news articles including new products, acquisitions and collaborations in each market are also dealt with in sufficient detail.
The report has also dealt with biobetters, their approval mechanisms and importance in the industry. (Biobetters are described as new molecular entities that are related to existing biologics by target or action, but they are deliberately altered to improve disposition, safety, efficacy, or manufacturing attributes.)
Comprehensive company profiles of key players in the market, including Allergan Plc., Bioton S.A., Cinnagen, Emcure Pharmaceuticals Ltd., LG Life Sciences, Neuclone and Pfizer Inc.
Key Topics Covered:
1 Introduction
2 Summary And Highlights
3 Market And Technology Background
4 Market Breakdown By Technology Type
5 Market Breakdown By Application
6 Market Breakdown By Region
7 Industry Structure
8 Patent Review
9 New Developments
10 Regulatory Aspects
11 Technologies Used In Biosimilar Manufacturing And Analytical Testing, Emerging Trends
12 Analysis Of Market Opportunities
13 Company Profiles
- 3S Bio Inc.
- Allergan PLC.
- Amgen Inc.
- Bharat Serums And Vaccines Ltd.
- Biocad
- Biocon Ltd.
- Biosidus S.A.
- Celltrion Inc.
- China National Biotec Group (Cnbg)
- Cinnagen
- Cipla Biotec Pvt. Ltd.
- Coherus Biosciences
- DM Bio Ltd.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Epirus Biopharmaceuticals Inc.
- Fujifilm Diosynth Biotechnologies
- Genexine Inc.
- Intas Pharmaceuticals Ltd.
- JCR Pharmaceuticals Co. Ltd.
- JHL Biotech Inc.
- Kissei Pharmaceutical Co. Ltd.
- LG Life Sciences
- Merck Kgaa
- Neuclone
- Nippon Kayaku Co. Ltd.
- Pfenex Inc.
- Pfizer Inc.
- Samsung Bioepis Co. Ltd.
- Sandoz International Gmbh
- Scinopharm Taiwan Ltd.
- Stada Arzneimittel Ag
- Tanvex Biopharma Inc.
- Teva Pharmaceuticals Industries Ltd
- Zydus Cadila
For more information about this report visit https://www.researchandmarkets.com/research/sg8n3n/global?w=4
